Salspera
Developing novel tumor microbiome immunotherapies for solid tumor cancers.
Developing novel tumor microbiome immunotherapies for solid tumor cancers.
Salspera is a clinical-stage biotechnology company committed to developing novel therapies for solid tumor cancers. The company has a platform of microbial immunotherapies that have the potential to address a range of solid tumor cancers where unmet medical need is high. We believe microbial immunotherapies could be used to create a new category of medicines with significant potential to improve the lives of patients.
There is no investment information
No recent news or press coverage available for Salspera.
We care about your data, and we'd love to use cookies make your experience better.